The concept of molecular machinery is useful for design of stimuli-responsive gene delivery systems in the mammalian cell

被引:0
作者
Takeshi Nagasaki
Seiji Shinkai
机构
[1] Osaka City University,Department of Applied Chemistry and Bioengineering, Graduate School of Engineering
[2] SORST Program,Department of Chemistry and Biochemistry, Graduate School of Engineering
[3] Japan Science and Technology Corporation,Center for Future Chemistry
[4] Kyushu University,undefined
[5] Kyushu University,undefined
来源
Journal of Inclusion Phenomena and Macrocyclic Chemistry | 2007年 / 58卷
关键词
Non-viral vector; Gene delivery; Stimuli-responsive systems; Molecular machinery; Photo-responsive systems; Transfection;
D O I
暂无
中图分类号
学科分类号
摘要
Since the first generation of molecular machines including photoresponsive crown ethers and its analogues was reported by Shinkai et al., a huge number of molecular machines exhibiting dynamic chemical and physical functions have been designed and developed. On the other hand, non-viral vectors are desired to possess conflicting properties to associate with DNA until reaching the nucleus as their final destination and dissociate from DNA there. In other words, non-viral vectors should work as a sort of molecular machinery. To overcome this dilemma, recently, much attention is focused on the development of the intelligent vectors, also called as ‘stimuli responsive vectors’ working as molecular machines. In this review, stimulus responsive gene delivery systems in which some structural factors and/or physiological properties are regulated in response to extracellular signals such as redox, pH, ultrasound, light, temperature, etc. are introduced as a new generation of non-viral vectors. These extracellular signals such as ultrasound, light, and temperature can be potent stimuli capable of site-, timing-, and duration-specific gene expression.
引用
收藏
页码:205 / 219
页数:14
相关论文
共 623 条
  • [1] Wiethoff C.M.(2004)Finishing the euchromatic sequence of the human genome Nature 431 931-945
  • [2] Middaugh C.R.(2003)Barriers to nonviral gene delivery J. Pharm. Sci. 92 203-217
  • [3] Wolkowicz R.(2005)Gene therapy progress and prospects: novel gene therapy approaches for AIDS Gene Ther. 12 467-476
  • [4] Nolan G.P.(2005)Current status of gene therapy strategies to treat HIV/AIDS Mol. Ther. 11 823-842
  • [5] Strayer D.S.(2005)DNA drug design for cancer therapy Curr. Pharm. Des. 11 2811-2823
  • [6] Akkina R.(2005)Gene therapy progress and prospects: Gene therapy for diabetes mellitus Gene Ther. 12 101-107
  • [7] Bunnell B.A.(2004)Perspective in progress of cardiovascular gene therapy. J. Pharm. Sci. 95 1-8
  • [8] Dropulic B.(2000)Gene therapy for lung disease: hype or hope? Ann. Intern. Med. 132 649-660
  • [9] Planelles V.(2002)Gene therapy progress and prospects: nonviral vectors Gene Ther. 9 1647-1652
  • [10] Pomerantz R.J.(2003)Gene therapy progress and prospects: gene therapy of lysosomal storage disorders Gene Ther. 10 1275-1281